SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.48+1.4%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (435)12/7/2003 10:45:30 PM
From: Jibacoa  Read Replies (1) of 3722
 
LCAV Is another stock which has had a good run since its UPTREND started on April 2 from the 3.60 level.<g>

THe stock was up more than 400% to its 20.20 H on its early upgap Friday, albeit it weakened some after the first hour.<g>

The stock seems to have already closed its upgap of November 25 and its nearest support is at 17.20 with resistance at 18.75 and then 20.20

The revenues for the September Q were more than 50% better compared to 2002 (20.5M vs, 13.5M) and the earnings showed an even better comparison as they were $0.14 vs. a loss of $0.28 For the December Q the company expects to report earnings of $0.10 vs a loss of $0.40 in 2002.

It seems OK to keep an eye on LCAV as long as it can hold above the 17.20 level.<g>

siliconinvestor.com

siliconinvestor.com

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext